ClinicalTrials.gg
Drug

Vibegron clinical trials

Also written MK-4618, RVT-901 and Gemtesa.

studies test it
14
open now
4
in phase 3
6
first study started
2011

How each study uses vibegron is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the vibegron studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Dec 2020 · GEMTESA · NDA 213006 (FDA, Drugs@FDA)
European Union
27 Jun 2024 · Obgemsa · EMEA/H/C/005957 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Vibegron
10

Brand

Gemtesa
3

Development codes

MK-4618
8
RVT-901
4
KRP-114V
4
URO-901
4

Studies by the year they started

14 studies that test it; most in 2018 (3)

Studies that test vibegron, by start year
YearStudies
20111
20122
20131
20183
20192
20221
20241
20251
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
3
Phase 2
3
Phase 3
6
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 4

Urovant Sciences GmbH (6) · Merck Sharp & Dohme LLC (4) · University of Missouri-Columbia (2) · Wake Forest University Health Sciences (1) · University of Alabama at Birmingham (1)

Often tested with

Tested in the same studies.

Tolterodine (2) · Propranolol (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test vibegron.

Studies

Open first, then newest update. How each study uses vibegron is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Given beside what is tested · 1 — vibegron is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 20, 2026.

Started recruiting1

Codes

What other systems call vibegron · ClinicalTrials.gg INT000476

  • UNII (FDA) M5TSE03W5UVIBEGRONConfirmed FDA, Wikidata
  • RxNorm 2472254One source FDA
  • Wikidata Q27283524vibegronConfirmed FDA, Wikidata
  • NCI Thesaurus C152872VibegronOne source FDA
  • DrugBank DB14895One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.